BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3741840)

  • 1. Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.
    Eastman A
    Biochemistry; 1986 Jul; 25(13):3912-5. PubMed ID: 3741840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstrand cross-links and sequence specificity in the reaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.
    Eastman A
    Biochemistry; 1985 Sep; 24(19):5027-32. PubMed ID: 4074675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione.
    Eastman A; Barry MA
    Biochemistry; 1987 Jun; 26(12):3303-7. PubMed ID: 3651385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli DNA polymerase I: inherent exonuclease activities differentiate between monofunctional and bifunctional adducts of DNA and cis- or trans-diamminedichloroplatinum(II). An exonuclease investigation of the kinetics of the adduct formation.
    Bernges F; Dörner G; Holler E
    Eur J Biochem; 1990 Aug; 191(3):743-53. PubMed ID: 2167853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum (II).
    Eastman A
    Anal Biochem; 1991 Sep; 197(2):311-5. PubMed ID: 1785684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).
    Eastman A
    Biochemistry; 1983 Aug; 22(16):3927-33. PubMed ID: 6225458
    [No Abstract]   [Full Text] [Related]  

  • 7. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D; Gaucheron F; Sip M; Leng M
    Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platination of a GG site on single-stranded and double-stranded forms of a 14-base oligonucleotide with diaqua cisplatin followed by NMR and HPLC -- influence of the platinum ligands and base sequence on 5'-G versus 3'-G platination selectivity.
    Reeder F; Guo Z; Murdoch PD; Corazza A; Hambley TW; Berners-Price SJ; Chottard JC; Sadler PJ
    Eur J Biochem; 1997 Oct; 249(2):370-82. PubMed ID: 9370343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
    Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
    Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
    Pérez C; Leng M; Malinge JM
    Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
    Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
    Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II).
    Eastman A; Jennerwein MM; Nagel DL
    Chem Biol Interact; 1988; 67(1-2):71-80. PubMed ID: 3262435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of monofunctional DNA adducts of cis-diamminedichloroplatinum (II) to bifunctional lesions. Effect on the in vitro replication of single-stranded DNA by Escherichia coli DNA polymerase I and eukaryotic DNA polymerases alpha.
    Hoffmann JS; Johnson NP; Villani G
    J Biol Chem; 1989 Sep; 264(25):15130-5. PubMed ID: 2670932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).
    Eastman A; Schulte N
    Biochemistry; 1988 Jun; 27(13):4730-4. PubMed ID: 3167012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation and characterization of products resulting from the reaction of cis-diamminedichloroplatinum (II) with deoxyribonucleosides.
    Eastman A
    Biochemistry; 1982 Dec; 21(26):6732-6. PubMed ID: 6891601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.
    Calsou P; Frit P; Salles B
    Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of an E. coli strain resistant to the toxic and mutagenic action of cis-diamminedichloroplatinum(II).
    Villani G; Lherisson C; Defais M; Johnson NP
    Mutat Res; 1987 Jan; 183(1):21-9. PubMed ID: 3540652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.